Marshall Wace
VECT

Marshall Wace’s VectivBio Holding AG Ordinary Shares VECT Stock Holding History

Marshall Wace’s Portfolio VECT Stock Details VECT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,669,656
Closed -$14.4M – 3157
2023
Q1 		$14.4M Buy
1,669,656
+300,000
+22% +$2.47M 0.03% 583
2022
Q4 		$11.8M Buy
1,369,656
+867,000
+172% +$6.98M 0.03% 720
2022
Q3 		$3.02M Hold
502,656
– – 0.01% 1743
2022
Q2 		$2.71M Buy
+502,656
New +$2.71M 0.01% 1786

Other funds holding VECT

OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
TCG Crossover Management
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CHI Advisors
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Vivo Capital
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Glazer Capital LLC
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
UBS O'Connor
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
Alpine Associates Management
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Versor Investments
Versor Investments New York $59.8M AUM 85.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Marshall Wace's VECT Position: Q2 2023 in Review

Marshall Wace sold out of VectivBio Holding AG Ordinary Shares (VECT) in Q2 2023, closing a stake of 1,669,656 shares — an estimated $14.4M sold.

Marshall Wace first reported a position in VECT in Q2 2022 and held it in 4 quarters. The position peaked at $14.4M in Q1 2023. 49 funds tracked by Wall St. Rank hold VECT as of Q2 2023.

  • Marshall Wace reported no remaining VectivBio Holding AG Ordinary Shares position as of Q2 2023 after selling out during the quarter.
  • Marshall Wace sold 1,669,656 VectivBio Holding AG Ordinary Shares shares in Q2 2023, an estimated $14.4M.
  • Marshall Wace first reported a position in VectivBio Holding AG Ordinary Shares in Q2 2022 and held it in 4 quarters.
  • Marshall Wace's VectivBio Holding AG Ordinary Shares position peaked at $14.4M in Q1 2023.
  • 49 funds tracked by Wall St. Rank held VectivBio Holding AG Ordinary Shares as of Q2 2023.

Based on Marshall Wace's 13F filing for Q2 2023, filed 14 Aug 2023.